AI 처방전 준수 도구

집

AI 프롬프트 목록

의료 건강

처방전 심사 보조자

${:__('collect %s',처방전 심사 보조자)}$

의료 건강

임상 지침에 따라 처방전을 자동으로 심사하고, 상호작용 및 용량 이상을 식별하여 표준화된 보고서를 생성합니다.

프롬프트 내용

복사

Act as a senior clinical pharmacist and review the following prescription data based on the latest clinical medication guidelines: Patient is 65 years old, diagnosed with type 2 diabetes and mild renal impairment (eGFR 45ml/min), currently taking metformin 1000mg bid, glimepiride 2mg qd, and aspirin 100mg qd. Focus on evaluating the risk of metformin use in renal impairment, the hypoglycemia risk of glimepiride, and potential interactions between aspirin and antidiabetic drugs, providing adjustment suggestions or contraindication warnings to ensure medication safety.

복사

최신 임상 약물 지침에 따라 다음 처방 데이터를 시니어 임상 약사로서 검토하십시오: 환자는 65세이며, 2형 당뇨병 및 경도 신기능 부전(eGFR 45ml/min) 진단을 받았고, 현재 메트포르민 1000mg bid, 글리메피리드 2mg qd, 아스피린 100mg qd를 복용 중입니다. 신기능 부전 상태에서의 메트포르민 사용 위험, 글리메피리드의 저혈당 위험, 그리고 아스피린과 항당뇨약의 잠재적 상호작용에 중점을 두고, 조정 제안 또는 금기 경고 제공을 통해 약물 안전성을 확보하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

처방전 심사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to highlight potential risks and provide adjustment suggestions, finally outputting a structured, professional audit report.

수술 후 재활 보조 도구

Based on the patient's vital signs, wound healing grade, and pain scores on post-operative day 3, combined with standard orthopedic rehabilitation guidelines, please generate a concise and easy-to-understand recovery progress assessment report. The report should include the current recovery stage judgment, potential risk warnings, and key home care suggestions for the next week. The language should be gentle and professional, avoiding complex medical jargon to ensure patient comprehension and compliance.

처방전 심사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.

처방전 심사 보조 도구

Act as a clinical pharmacist and review the provided physician's prescription against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing drug-drug interactions, dosage appropriateness, compatibility issues, and adherence to specific physiological conditions such as renal impairment or pregnancy. Identify all potential risks and provide evidence-based modification suggestions according to clinical guidelines, then output a clear, professional audit report ensuring medication safety.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription. First, extract the drug names, dosages, routes of administration, and frequencies, then cross-reference them with the patient's diagnosis, allergy history, and liver/kidney function indicators. Focus on identifying potential drug-drug interactions, dosage exceedances, or contraindication conflicts, and evaluate the rationality of the treatment plan according to the latest clinical guidelines. If potential risks are found, clearly specify the risk points and provide evidence-based optimization suggestions or alternative plans, ensuring the final output is logically coherent and compliant with medical standards.

처방전 심사 보조

Act as a senior clinical pharmacist and review the following prescription for compliance: The patient is a 65-year-old male with a history of chronic kidney disease (creatinine clearance 45ml/min) and hypertension. The current prescription includes Amoxicillin, Amlodipine, and Ibuprofen. Focus on analyzing drug-drug interactions, the necessity for dosage adjustments, and potential nephrotoxicity risks, providing recommendations aligned with clinical guidelines.